CNBC Investing Club

Cramer's Investing Club: We believe the market is wrong on core holding Abbott's future potential

Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada.
Ethan Miller | Getty Images

Charitable trust stock Abbott Labs (ABT) reported fourth-quarter earnings before the opening bell on Wednesday. On the top line, sales of $11.5 billion (+7.7% YoY organic) exceeded the $10.64 billion consensus. On the bottom line, adjusted diluted earnings of $1.32 per share (-9.0% YoY) outpaced the $1.19 per share consensus.

More In CNBC Investing Club Newsletter

CNBC Investing ClubNew analyst reports support our view of Constellation as a great defensive play
CNBC Investing ClubWall Street notes on Apple, Qualcomm highlight the long-term opportunities in those stocks
CNBC Investing ClubTuesday's market bounce allows us to raise some cash to buy in the next downturn